Is the Correction Over? Part 2
The good news is that the cannabis industry in North America is booming. Legal recreational sales in Canada are very healthy, with the only problem being a supply shortage—which will be alleviated in the months ahead. And legal continues...
Read More
Is the Correction Over?
Last Tuesday, the day before the opening of the legal commercial market for marijuana in Canada, I sent you an update that said, in part, “I believe the odds are that this will mark an intermediate-term top for many of stocks...
Read More
October 17 Approaches!
First, I want to welcome all my new readers to the first issue of Cabot Marijuana Investor, the successor to the quarterly report that was Cabot’s Ten Best Marijuana stocks. When I started that report back in August 2017, I was about...
Read More
Dear Investor,
Three months ago, when our previous full issue was published, the race for first place in the young and fast-growing cannabis industry was neck-and-neck, with acquisitive Aurora challenging Canopy Growth. But today, in the wake of Constellation Brands’ massive $4 billion investment Canopy,...
Read More
When I consider the icons who made contributions to the science of investing, many names come to mind.
Read More
Those of us who work the growth investing side of things here at Cabot certainly enjoy the stock selection process.
Read More
Here's what I wrote about Barrick in last week's edition of Cabot Top Ten: The price of gold is in a solid uptrend, and that's helping all gold stocks, including Barrick Gold. The company, based in Canada, is one of the largest gold in...
Read More